Three LMU researchers elected to Leopoldina

Frederick Klauschen, Director of the Institute of Pathology at LMU, has now become a member of the Pathology and Forensic Medicine Section of the Leopoldina. His research focuses on artificial intelligence in medicine and the integration of histological and proteogenomic imaging methods in cancer research. His aim is to better understand and predict pathological mechanisms in tumors and thus to better diagnose and treat cancer.

Claudia Bausewein, Chair of Palliative Medicine at LMU, has been elected to the Global Health section of the Academy of Science. She is Director of the Clinic and Polyclinic for Palliative Medicine at LMU Hospital. Her research interests include the complexity of palliative care, respiratory distress in patients with advanced illnesses, sedation at the end of life and drug therapy in palliative care.

Markus M. Lerch, Medical Director and Chairman of the Board of LMU Klinikum, has been elected a member of the Internal Medicine and Dermatology Section of the German Academy of Sciences Leopoldina. Before his appointment to Munich, the specialist in internal medicine, gastroenterology, endocrinology and biochemistry was Clinic Director at Greifswald University Hospital. His clinical and scientific focus is on the pathophysiology, cell biology and genetics of pancreatic diseases and improving the treatment of affected patients.

With more than 360 years of existence, the Leopoldina is the oldest continuously existing science academy in the world. One of its main tasks is to provide science-based advice to politicians and the public. Another is to represent German science in international bodies. In 2008, the Leopoldina, now based in Halle an der Saale, was appointed Germany's National Academy of Sciences. Most of its members come from Germany, Austria and Switzerland.